BioNTech Common Stock Shares Outstanding from 2010 to 2024

BNTX Stock  USD 111.48  5.16  4.85%   
BioNTech Common Stock Shares Outstanding yearly trend continues to be fairly stable with very little volatility. Common Stock Shares Outstanding will likely drop to about 229.1 M in 2024. Common Stock Shares Outstanding is the total number of shares of a company's common stock that are currently owned by all its shareholders. View All Fundamentals
 
Common Stock Shares Outstanding  
First Reported
2018-09-30
Previous Quarter
237.7 M
Current Value
237.8 M
Quarterly Volatility
13.9 M
 
Covid
Check BioNTech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioNTech's main balance sheet or income statement drivers, such as Tax Provision of 243 M, Net Interest Income of 367.2 M or Interest Income of 375.5 M, as well as many indicators such as Price To Sales Ratio of 5.77, Dividend Yield of 0.0111 or PTB Ratio of 1.2. BioNTech financial statements analysis is a perfect complement when working with BioNTech Valuation or Volatility modules.
  
Check out the analysis of BioNTech Correlation against competitors.

Latest BioNTech's Common Stock Shares Outstanding Growth Pattern

Below is the plot of the Common Stock Shares Outstanding of BioNTech SE over the last few years. It is the total number of shares of a company's common stock that are currently owned by all its shareholders. BioNTech's Common Stock Shares Outstanding historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in BioNTech's overall financial position and show how it may be relating to other accounts over time.
Common Stock Shares Outstanding10 Years Trend
Slightly volatile
   Common Stock Shares Outstanding   
       Timeline  

BioNTech Common Stock Shares Outstanding Regression Statistics

Arithmetic Mean126,334,119
Geometric Mean0.00
Coefficient Of Variation97.23
Mean Deviation117,911,845
Median211,499,000
Standard Deviation122,836,225
Sample Variance15088.7T
Range259.7M
R-Value0.88
Mean Square Error3758.5T
R-Squared0.77
Significance0.000018
Slope24,081,820
Total Sum of Squares211242.3T

BioNTech Common Stock Shares Outstanding History

2024229.1 M
2023242.7 M
2022249.8 M
2021259.7 M
2020248.5 M
2019211.5 M

About BioNTech Financial Statements

BioNTech investors use historical fundamental indicators, such as BioNTech's Common Stock Shares Outstanding, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in BioNTech. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Common Stock Shares Outstanding242.7 M229.1 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for BioNTech Stock Analysis

When running BioNTech's price analysis, check to measure BioNTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioNTech is operating at the current time. Most of BioNTech's value examination focuses on studying past and present price action to predict the probability of BioNTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioNTech's price. Additionally, you may evaluate how the addition of BioNTech to your portfolios can decrease your overall portfolio volatility.